KR20100072283A - 환자의 유전자-베이스 알고리즘적 암 예후 및 임상적 결과 - Google Patents

환자의 유전자-베이스 알고리즘적 암 예후 및 임상적 결과 Download PDF

Info

Publication number
KR20100072283A
KR20100072283A KR1020107008764A KR20107008764A KR20100072283A KR 20100072283 A KR20100072283 A KR 20100072283A KR 1020107008764 A KR1020107008764 A KR 1020107008764A KR 20107008764 A KR20107008764 A KR 20107008764A KR 20100072283 A KR20100072283 A KR 20100072283A
Authority
KR
South Korea
Prior art keywords
cancer
genes
gene
tumor sample
diagnostic kit
Prior art date
Application number
KR1020107008764A
Other languages
English (en)
Korean (ko)
Inventor
크리스토스 소티리오우
버지니에 두르벡크
Original Assignee
유니베르시테 리브레 드 브룩크젤즈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유니베르시테 리브레 드 브룩크젤즈 filed Critical 유니베르시테 리브레 드 브룩크젤즈
Publication of KR20100072283A publication Critical patent/KR20100072283A/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
KR1020107008764A 2007-10-30 2008-04-16 환자의 유전자-베이스 알고리즘적 암 예후 및 임상적 결과 KR20100072283A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/929,043 US20080275652A1 (en) 2005-05-13 2007-10-30 Gene-based algorithmic cancer prognosis
US11/929,043 2007-10-30

Publications (1)

Publication Number Publication Date
KR20100072283A true KR20100072283A (ko) 2010-06-30

Family

ID=39629069

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107008764A KR20100072283A (ko) 2007-10-30 2008-04-16 환자의 유전자-베이스 알고리즘적 암 예후 및 임상적 결과

Country Status (10)

Country Link
US (2) US20080275652A1 (ja)
EP (1) EP2203571A1 (ja)
JP (1) JP2011500071A (ja)
KR (1) KR20100072283A (ja)
CN (1) CN101861400A (ja)
AU (1) AU2008317851A1 (ja)
CA (1) CA2700906A1 (ja)
IL (1) IL205359A0 (ja)
WO (1) WO2009056366A1 (ja)
ZA (1) ZA201002312B (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009030770A2 (en) * 2007-09-07 2009-03-12 Universite Libre De Bruxelles Methods and tools for prognosis of cancer in er- patients
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
WO2012006447A2 (en) 2010-07-07 2012-01-12 Myriad Genetics, Inc. Gene signatures for cancer prognosis
WO2012006421A2 (en) * 2010-07-07 2012-01-12 The Regents Of The University Of Michigan Diagnosis and treatment of breast cancer
DK3147373T3 (da) 2010-07-27 2019-08-12 Genomic Health Inc Fremgangsmåde til anvendelse af genekspression til at bestemme prognosen for prostatacancer
CA2809829A1 (en) 2010-08-30 2012-03-08 Myriad Genetics, Inc. Gene signatures for cancer diagnosis and prognosis
US20130226621A1 (en) * 2010-11-01 2013-08-29 Koninklijke Philips Electronics N.V. In vitro diagnostic testing including automated brokering of royalty payments for proprietary tests
US20140113297A1 (en) * 2011-03-26 2014-04-24 Oregon Health & Science University Gene expression predictors of cancer prognosis
WO2014078700A1 (en) 2012-11-16 2014-05-22 Myriad Genetics, Inc. Gene signatures for cancer prognosis
KR101504817B1 (ko) 2013-04-05 2015-03-24 연세대학교 산학협력단 국소 진행형 위암에 대한 예후 예측 시스템
CN105706097A (zh) * 2013-06-28 2016-06-22 南托米克斯有限责任公司 用于诊断检测的识别的途径分析
CA2930972A1 (en) * 2013-12-04 2015-06-11 Myriad Genetics, Inc. Gene signatures for renal cancer prognosis
CA2947624A1 (en) 2014-05-13 2015-11-19 Myriad Genetics, Inc. Gene signatures for cancer prognosis
ES2753625T3 (es) * 2014-09-19 2020-04-13 The Provost Fellows Found Scholars & The Other Members Of Board Of The College Of The Holy & Undiv T Un método para predecir el riesgo de recaída del cáncer
US10174382B2 (en) * 2015-05-13 2019-01-08 University Of Notre Dame Breast cancer prognostication and screening kits and methods of using same
WO2018095933A1 (en) * 2016-11-22 2018-05-31 Université D'aix-Marseille (Amu) Method of prognosticating, or for determining the efficiency of a compound for treating cancer
SG11201906318WA (en) * 2017-02-13 2019-08-27 Genomic Health Inc Algorithms and methods for assessing late clinical endpoints in prostate cancer
CN107227342A (zh) * 2017-05-04 2017-10-03 上海大学 前列腺癌诊断用基因组及其应用
CN110993104B (zh) * 2019-12-03 2023-06-30 中国医科大学附属第一医院 肿瘤患者生存期预测系统
CN111172285A (zh) * 2020-02-26 2020-05-19 江南大学附属医院 用于胰腺癌早期诊断和/或预后监测的miRNA组及其应用
JP2023520118A (ja) * 2020-04-03 2023-05-16 クオリシュア・ダイアグノスティックス・インコーポレイテッド 甲状腺がんのための予後予測方法及び処置方法
CN113444804B (zh) * 2021-07-14 2022-03-15 武汉大学中南医院 宫颈癌预后相关基因及其在制备宫颈癌预后预测诊断产品中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030198972A1 (en) * 2001-12-21 2003-10-23 Erlander Mark G. Grading of breast cancer
SI1581812T1 (sl) * 2003-01-06 2008-10-31 Wyeth Corp Sestavki in postopki za diagnosticiranje in zdravljenje raka kolona
US20040231909A1 (en) * 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
US20050266409A1 (en) * 2003-02-04 2005-12-01 Wyeth Compositions and methods for diagnosing, preventing, and treating cancers
US20040191783A1 (en) * 2003-03-31 2004-09-30 Guy Leclercq Low density micro-array analysis in human breast cancer
EP3170906B1 (en) * 2003-06-24 2018-08-22 Genomic Health, Inc. Prediction of likelihood of cancer recurrence
JP2008539737A (ja) * 2005-05-13 2008-11-20 ユニヴェルシテ リブル ドゥ ブリュッセル 遺伝子に基づくアルゴリズム的ガン予後
WO2009030770A2 (en) * 2007-09-07 2009-03-12 Universite Libre De Bruxelles Methods and tools for prognosis of cancer in er- patients
CA2695814A1 (en) * 2007-09-07 2009-04-23 Universite Libre De Bruxelles Methods and tools for prognosis of cancer in her2+ patients

Also Published As

Publication number Publication date
EP2203571A1 (en) 2010-07-07
AU2008317851A1 (en) 2009-05-07
CN101861400A (zh) 2010-10-13
IL205359A0 (en) 2010-12-30
US20080275652A1 (en) 2008-11-06
JP2011500071A (ja) 2011-01-06
ZA201002312B (en) 2011-06-29
WO2009056366A1 (en) 2009-05-07
US20120071346A1 (en) 2012-03-22
CA2700906A1 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
KR20100072283A (ko) 환자의 유전자-베이스 알고리즘적 암 예후 및 임상적 결과
Rahbari et al. Identification of differentially expressed microRNA in parathyroid tumors
US8492102B2 (en) Molecular diagnosis and classification of malignant melanoma
US20090280493A1 (en) Methods and Compositions for the Prediction of Response to Trastuzumab Containing Chemotherapy Regimen in Malignant Neoplasia
WO2009158620A2 (en) Signatures and determinants associated with metastasis methods of use thereof
US20110159496A1 (en) Molecular diagnosis and classification of malignant melanoma
US20100178651A1 (en) Bifunctional Predictors of Cancer Treatment Sensitivity and Resistance
US11827938B2 (en) Methods of prostate cancer prognosis
US20160355889A1 (en) Method to assess prognosis and to predict therapeutic success in cancer by determining hormone receptor expression levels
US20130143753A1 (en) Methods for predicting outcome of breast cancer, and/or risk of relapse, response or survival of a patient suffering therefrom
TW201827603A (zh) 用於膀胱癌預後的生物標記物組合
ES2856232B2 (es) Biomarcadores para predecir la respuesta de un sujeto a una terapia con bcg, metodos y usos basados en los mismos
WO2009068409A1 (en) A method to assess prognosis and to predict therapeutic response to endocrine treatment
EP2065473A1 (en) A method to assess prognosis and to predict therapeutic success in gynecologic cancer
US20110269636A1 (en) Materials and methods for identifying patients at heighten risk for developing her2+ related brain tumors
WO2008125791A1 (en) Cancer markers
KR20170004638A (ko) 갈색세포종 진단용 조성물

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid